Nishadil
Signup Signin
Delhi | 25°C (windy)
Is Pharma Poised for a Powerful Rebound? Chart Master Sees a Major Breakout Ahead

Is Pharma Poised for a Powerful Rebound? Chart Master Sees a Major Breakout Ahead
Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope

Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope
The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing

The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing
Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina

Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina
The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer
Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway
Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead

Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead
RFK Jr.'s Vaccine Panel Set to Ignite New Debate on COVID-19 Shot Guidance

RFK Jr.'s Vaccine Panel Set to Ignite New Debate on COVID-19 Shot Guidance
Healthcare's Pulse Check: Why High-Yield Dividends Might Be Your Best Bet in a Struggling Sector

Healthcare's Pulse Check: Why High-Yield Dividends Might Be Your Best Bet in a Struggling Sector
Load more..